Author

Russell D. Patmore

Observed names: R Patmore, R. D. PATMORE, R. D. Patmore, R. Patmore, Russell D Patmore, Russell Patmore

Observed institutions: Leeds General Infirmary, University of Leeds, University of Nottingham, University of Hull, Université Clermont Auvergne, Hull University Teaching Hospitals NHS Trust, Hull Royal Infirmary, Castle Hill Hospital, Huddersfield Royal Infirmary, Nottingham City Hospital, Centre Hospitalier Universitaire de Bordeaux, Assistance Publique – Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Queen's Medical Centre, Hôpital Saint-Louis, Université Pierre-et-Marie-Curie, University of York, Hull York Medical School, University of Birmingham

ORCID: 0000-0002-0925-9014

Observed ORCID: 0000-0002-0925-9014

OpenAlex ID: A5078478289

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network

2011 · A Smith, D Howell, et al. · British Journal of Cancer · 692

PDF

Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab

2010 · Sharon Barrans, Simon Crouch, et al. · Journal of Clinical Oncology · 552

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

2020 · Stuart E. Lacy, Sharon L. Barrans, et al. · Blood · 505

PDF

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network

2015 · A Smith, S Crouch, et al. · British Journal of Cancer · 424

PDF

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

2002 · Sharon L. Barrans, Ian Carter, et al. · Blood · 276

PDF

Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data

2011 · Debra A Howell, Rhiannon Shellens, et al. · Palliative Medicine · 239

Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation

2002 · Andy C. Rawstron, Faith E. Davies, et al. · Blood · 210

Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenström Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma

2012 · Véronique Leblond, Steve Johnson, et al. · Journal of Clinical Oncology · 154

The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research

2009 · Alexandra Smith, Eve Roman, et al. · British Journal of Haematology · 146

PDF

Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network

2013 · Debra A Howell, Alexandra G Smith, et al. · BMC Blood Disorders · 128

PDF

Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy

2010 · Debra A Howell, Eve Roman, et al. · BMC Palliative Care · 122

PDF

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15

2016 · Eve Roman, Alex Smith, et al. · Cancer Epidemiology · 110

PDF

Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B ‐cell lymphoma and predict clinical outcome

2012 · Sharon L. Barrans, Simon Crouch, et al. · British Journal of Haematology · 100

PDF

Preferred and actual place of death in haematological malignancy

2015 · D A Howell, H I Wang, et al. · BMJ Supportive & Palliative Care · 78

PDF

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma

2015 · Alexandra Smith, Simon Crouch, et al. · Cancer Epidemiology · 70

PDF

Palliative care specialists’ perceptions concerning referral of haematology patients to their services: findings from a qualitative study

2018 · Dorothy McCaughan, Eve Roman, et al. · BMC Palliative Care · 69

PDF

Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial

2020 · A.K. McMillan, E.H. Phillips, et al. · Annals of Oncology · 63

PDF

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort

2018 · Alexandra Smith, Debra Howell, et al. · International Journal of Epidemiology · 62

PDF

Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a UK population‐based study

2017 · Debra Howell, Alexandra Smith, et al. · British Journal of Haematology · 59

PDF

Determinants of survival in patients with chronic myeloid leukaemia treated in the new era of oral therapy: findings from a UK population-based patient cohort

2014 · A G Smith, D Painter, et al. · BMJ Open · 56

PDF

Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients

2021 · Rory McCulloch, David Lewis, et al. · British Journal of Haematology · 54

PDF

Determinants of hospital death in haematological cancers: findings from a qualitative study

2017 · Dorothy McCaughan, Eve Roman, et al. · BMJ Supportive & Palliative Care · 47

PDF

Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers—A qualitative study from the UK’s Haematological Malignancy Research Network

2022 · Debra A. Howell, Dorothy McCaughan, et al. · PLoS ONE · 46

PDF

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK 's Haematological Malignancy Research Network ( HMRN )

2018 · Alexandra Smith, Eve Roman, et al. · British Journal of Haematology · 46

PDF

Place of death in haematological malignancy: variations by disease sub-type and time from diagnosis to death

2013 · Debra A Howell, Han-I Wang, et al. · BMC Palliative Care · 44

PDF

Works count: 106

Citation count: 5,108

H-index: 32

I10-index: 52